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studied the effect of ghrelin infusions in 
rats with renal failure. They found that 
such treatment resulted in the expected 
increased appetite, but in pair-fed rats, 
there was stimulation of mitochondrial 
enzymes. There was also lower triglyc-
eride content. Finally, the regulators of 
mitochondrial biogenesis deficient in ure-
mic animals were normalized after treat-
ment with ghrelin. The most interesting 
result here is that ghrelin produced these 
effects independently of food intake. The 
combined effect of increased food intake 
and improved muscle metabolism makes 
ghrelin an attractive therapeutic agent to 
combat uremic cachexia. See page 23.
Vasopressin levels  
and microalbuminuria
It is now well known that microalbuminu-
ria is a powerful predictor of cardiovascular 
morbidity and mortality in addition to its 
Atherosclerotic 
renovascular disease
As they report in this issue, Kalra et 
al. analyzed the US Renal Data Sys-
tem to examine the incidence and risk 
of atheromatous renovascular disease. 
They found that the diagnosis of this 
condition increased with time, as did the 
revascularization. However, only about 
13% of patients so diagnosed underwent 
revascularization within 6 months of the 
diagnosis. The method of revasculariza-
tion changed, going from surgical inter-
vention to more endovascular treatment 
more recently. Unfortunately, the study, 
being retrospective with no access to the 
degree of the renal artery stenosis, could 
not answer the question on the minds of 
clinicians: does revascularization improve 
blood pressure control and outcome? 
See page 37.
Ghrelin and  
muscle mass in CKD
Uremia is associated with a decline in 
muscle mass due to a complex series of 
events whereby muscle protein becomes 
more susceptible to degradation. There 
is also evidence that muscle mito-
chondria biogenesis is reduced as well. 
Recently, the gastric hormone ghrelin 
has been used in uremic patients, result-
ing in increased appetite. Barazzoni et al. 
obvious role in predicting renal disease. 
Of the factors that can cause albuminuria, 
angio tensin II has long been known to be 
the culprit, and recent studies have shown 
that vasopressin receptor agonists increase 
urinary albumin excretion. As they report in 
this issue, Meijer et al. measured copeptin, 
a peptide that is secreted with vasopressin 
but that has a longer half-life in the plasma. 
They studied 7593 patients in a prospective 
population where albumin excretion was 
measured twice. They found that copeptin 
levels correlated with microalbuminuria, an 
association that was independent of poten-
tial confounders. These studies establish 
the correlation and suggest that further 
studies are needed to determine whether 
it is causal. If a causal link is established, 
then reducing vasopressin levels—say, by a 
high water intake—would be a cheap and 
effective way to reduce cardio vascular risk. 
See page 29.   
It’s now cheaper to print color figures in KI
Have you been concerned in the past about the cost of print-
ing color figures in Kidney International (KI)? KI has listened 
to your concerns and is now offering permanently reduced 
pricing for color figures—a flat fee of $500 per printed page, 
no matter how many color figures are on a page. This pricing 
is more affordable for authors and competitive with other top 
scientific journals. We want to make it easier for authors to 
publish the color figures that demonstrate important scien-
tific findings, and our new pricing reflects our commitment to 
achieving this goal.
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